Cosmo Rossi
Impact in
- Biochemistry top 2%
- Phytochemicals and Antioxidant Activities
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
Papers in
- Oncology 21
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 5
-
- Protease and Inhibitor Mechanisms 4
- Co-authors
- Mauro PiantelliAurélie SchoubbenPaolo BlasiStefano GiovagnoliMaurizio RicciAndreina PoggiPier Giorgio NataliStefano Iacobelli
- Journals
- Cancer Research (4 papers)International Journal of Cancer (3 papers)PLoS ONE (3 papers)Food and Chemical Toxicology (2 papers)Annals of Oncology (2 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Cosmo Rossi
69 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 138
- Biochemistry 211
- Pharmaceutical Science 208
- Oncology 741
- Cancer Research 345
- Molecular Biology 1.5k
Countries citing papers authored by Cosmo Rossi
This map shows the geographic impact of Cosmo Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cosmo Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cosmo Rossi more than expected).
Fields of papers citing papers by Cosmo Rossi
This network shows the impact of papers produced by Cosmo Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cosmo Rossi. The network helps show where Cosmo Rossi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cosmo Rossi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 15 | |
| 2 | 2020 | 8 | |
| 3 | 2020 | 11 | |
| 4 | 2018 | 28 | |
| 5 | 2015 | 30 | |
| 6 | 2014 | 28 | |
| 7 | 2013 | 15 | |
| 8 | 2010 | 36 | |
| 9 | 2010 | 9 | |
| 10 | 2009 | 57 | |
| 11 | 2008 | 112 | |
| 12 | 2008 | 74 | |
| 13 | 2006 | 7 | |
| 14 | 2005 | 103 | |
| 15 | 2001 | 66 | |
| 16 | 2000 | 379 | |
| 17 | 1999 | 17 | |
| 18 | 1999 | 100 | |
| 19 | 1993 | 29 | |
| 20 | 1991 | 21 |
About Cosmo Rossi
Cosmo Rossi is a scholar working on Oncology, Cancer Research, Immunology and Allergy, Molecular Biology and Geriatrics and Gerontology, having authored 70 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (5 papers), Cancer Treatment and Pharmacology (5 papers), Protease and Inhibitor Mechanisms (4 papers), Neuroblastoma Research and Treatments (4 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Biochemistry (211 citations), Pharmaceutical Science (208 citations), Oncology (741 citations), Cancer Research (345 citations) and Molecular Biology (1.5k citations). Cosmo Rossi has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Mauro Piantelli, Aurélie Schoubben, Paolo Blasi, Stefano Giovagnoli, Maurizio Ricci, Andreina Poggi, Pier Giorgio Natali, Stefano Iacobelli, Maurizio D’Incalci and Mauro Brunetti. Their work appears in journals such as Cancer Research, International Journal of Cancer, PLoS ONE, Food and Chemical Toxicology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.